Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone De Nitto

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Practical Laboratory Medicine|January 24, 2022
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassayGian Luca Salvagno, Laura Pighi, Simone De Nitto, et al.
Chronobiology International|December 27, 2023
Vaccination time does not influence total anti-SARS-CoV-2 antibodies responseLaura Pighi, Simone De Nitto, Gian Luca Salvagno, et al.
Advances in Laboratory Medicine|December 11, 2023
Simone De Nitto, Laura Pighi, Gian Luca Salvagno, et al.
Advances in Laboratory Medicine|December 11, 2023
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2Simone De Nitto, Laura Pighi, Gian Luca Salvagno, et al.
EJIFCC|January 6, 2023
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen ConcentrationGian Luca Salvagno, Brandon M Henry, Simone De Nitto, et al.
Advances in Laboratory Medicine|June 26, 2023
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workersGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
The Journal of Infection|April 10, 2022
Serum C reactive protein predicts humoral response after BNT162b2 booster administrationGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Advances in Laboratory Medicine|December 11, 2023
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?Giuseppe Lippi, Brandon M Henry, Laura Pighi, et al.
EJIFCC|October 31, 2022
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous BoosterGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
The New Microbiologica|December 20, 2022
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassayGian Luca Salvagno, Brandon M Henry, Simone De Nitto, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Practical Laboratory Medicine|January 24, 2022
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassayGian Luca Salvagno, Laura Pighi, Simone De Nitto, et al.
Chronobiology International|December 27, 2023
Vaccination time does not influence total anti-SARS-CoV-2 antibodies responseLaura Pighi, Simone De Nitto, Gian Luca Salvagno, et al.
Advances in Laboratory Medicine|December 11, 2023
Simone De Nitto, Laura Pighi, Gian Luca Salvagno, et al.
Advances in Laboratory Medicine|December 11, 2023
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2Simone De Nitto, Laura Pighi, Gian Luca Salvagno, et al.
EJIFCC|January 6, 2023
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen ConcentrationGian Luca Salvagno, Brandon M Henry, Simone De Nitto, et al.
Advances in Laboratory Medicine|June 26, 2023
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workersGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
The Journal of Infection|April 10, 2022
Serum C reactive protein predicts humoral response after BNT162b2 booster administrationGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Advances in Laboratory Medicine|December 11, 2023
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?Giuseppe Lippi, Brandon M Henry, Laura Pighi, et al.
EJIFCC|October 31, 2022
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous BoosterGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
The New Microbiologica|December 20, 2022
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassayGian Luca Salvagno, Brandon M Henry, Simone De Nitto, et al.
Pageof 4